K. Isshi

发表

Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus.

S. Hirohata, K. Isshi, 1996, Arthritis and rheumatism.

Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.

S. Hirohata, K. Isshi, 1998, Arthritis and rheumatism.

Synergistic inhibition of human B cell activation by gold sodium thiomalate and auranofin.

K. Nakanishi, S. Hirohata, T. Yanagida, 1999, Clinical immunology.

The role of carrier protein in the sensitivity of enzyme-linked immunosorbent assay for antiribosomal P protein antibodies: further comment on the article by Yoshio et al.

S. Hirohata, S. Toyoshima, K. Isshi, 1999, Arthritis and rheumatism.

Purity of synthetic ribosomal P peptides in enzyme-linked immunosorbent assay: comment on the article by Yoshio et al.

S. Hirohata, S. Toyoshima, K. Isshi, 1998, Arthritis and rheumatism.

Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.

T. Hashimoto, A. Takeuchi, S. Hirohata, 1997, Clinical immunology and immunopathology.

Inhibitory effects of bucillamine on the expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.

H. Kikuchi, S. Hirohata, K. Isshi, 2004, International immunopharmacology.

Systemic lupus erythematosus presenting with diffuse low density lesions in the cerebral white matter on computed axial tomography scans: its implication in the pathogenesis of diffuse central nervous system lupus.

T. Hashimoto, S. Hirohata, H. Miyashita, 1994, The Journal of rheumatology.

Association between serum IgG antibodies to recombinant ribosomal P0 fusion protein and neuropsychiatric systemic lupus erythematosus.

S. Hirohata, S. Toyoshima, K. Isshi, 1998, Arthritis and rheumatism.

Association of anti–ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus

S. Hirohata, K. Isshi, 1996 .